Anzeige
Mehr »
Login
Freitag, 10.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Innocan Pharma News: Unfassbare Studie - LPT-Therapie bewahrt Patient vor dem Tod!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
SGX News
186 Leser
Artikel bewerten:
(0)

CHINA SUN BIOCHEM TECH GP CO.: ANNOUNCEMENT OF CESSATION AS CHIEF FINANCIAL OFFICER

Announcement of Cessation of Chief Financial Officer
* Asterisks denote mandatory information
Name of Announcer *CHINA SUN BIOCHEM TECH GP CO.
Company Registration No.CT-136769
Announcement submitted on behalf ofCHINA SUN BIOCHEM TECH GP CO.
Announcement is submitted with respect to *CHINA SUN BIOCHEM TECH GP CO.
Announcement is submitted by *SUN GUIJI
Designation *EXECUTIVE CHAIRMAN AND CHIEF EXECUTIVE OFFICER
Date & Time of Broacast12-Nov-2009 12:05:35
Announcement No.00034
Price SensitivityNo
>> Announcement Details
The details of the announcement start here ...
Name *WONG CHI KWAN
Age *46
Is Effective Date of Cessation known? *Yes
Effective Date of Resignation01/12/2009
Detailed Reason(s) for cessation *To assume appointment and employment in another company with better and more secured prospects.
Is there any difference of opinion on material matters between the person and the Board of directors? *No
If yes, please elaborate *NA
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer? *No
Date of Appointment to current position *16/05/2006
Job Title *Chief Financial Officer
Role and responsibilities *Overseeing matters relating to accounting, financial administration and the compliance and reporting obligations of the Group.
Does the AC have a minimum of 3 members (taking into account this cessation) *Yes
Number of Independent Directors currently resident in Singapore (taking into account this resignation) *3
Number of Cessations of persons specified in Rule 704(7) of the Listing Manual over the past 12 months *0
Interest in the listed issuer and its subsidiaries *Nil.
Family relationship with any director and/or substantial shareholder of the listed issuer or of any of its principal subsidiaries *Nil.
>> Other Directorship #
# These fields are not applicable for announcements of appointments pursuant to Rule 704(9)
Past (for the last five years) *Nil.
Present *Nil.
FootnotesNil.
Lithium vs. Palladium - Ist das die Chance des Jahrzehnts?
Sichern Sie sich den kostenlosen PDF-Report! So können Sie vom Boom der Rohstoffe profitieren.
Hier klicken
© 2009 SGX News
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.